Optometry

Latest News


CME Content


Jobs in a down economy

The author says that is is a source of pride and relief that, in the middle of the recession, his son recently became a gainfully employed citizen and taxpayer.

If you are not a technician, how can you survive the jungle of managing a staff of technicians? Go back to the age of dinosaurs.

Results of a study applying image quality metrics already in use by the photography industry provide better understanding of the imaging properties of existing presbyopia-correcting IOLs.

Results from 6 months of follow-up in a prospective, multicenter European clinical trial show that the toric version of the foldable iris-fixated phakic IOL provides stable, effective correction of myopic astigmatism with a high safety index.

Maximizing depth of field

Patients can achieve adequate uncorrected far and near vision with an increase of the depth of field with Q-adjustment and monovision.

Optimal results from surgical correction of brow ptosis depend on a thorough knowledge of available procedures and the results of each of these will have on brow shape and symmetry.

The Wilmer Eye Institute of the Johns Hopkins University School of Medicine was to hold its 28th annual Current Concepts in Ophthalmology Course on March 14-18.

LASIK on thin corneas?

Findings from a retrospective analysis including 81,715 consecutive LASIK-treated eyes provide no evidence after 12 to 24 months of follow-up that a "thin cornea" increases the risk for postoperative ectasia.

International Vision Expo East, March 16 to 20 in New York City, will showcase exhibitors from around the world and provide the opportunity to touch, learn about, and experience firsthand the many products and services available to the optical community.

The International Vision Expo East and Conference was to celebrate its 25th year, March 16 to 20, at the Jacob K. Javits Convention Center here.

Pooled results from two prospective, multicenter, double-masked, placebo-controlled studies show a multi-modal anti-allergy product, bepotastine besilate ophthalmic solution 1.5%, provides rapid and long-lasting clinically significant improvement in allergen-induced ocular itching.

Epinastine hydrochloride ophthalmic solution 0.05% is a reliable, fast-acting treatment for patients with itching associated with allergic conjunctivitis.

Near-term results from a study assessing the effects of patient age on the safety and efficacy of LASIK for the treatment of myopia indicate that young adults do equally well as their older counterparts.

In the first in-human study fo human umbilical tissue-derived cells as cell-based therapy for retinal degenerative diseases, all seven patients tolerated the subretinal injection well and had no postoperative visual loss.